Lorna Warwick (she/her/hers)

CEO
Lymphoma Coalition

Lorna was appointed CEO of the Lymphoma Coalition in December 2018, to provide vision and leadership for the over 80-member strong organisation, having previous been the Coalition’s Director of Strategic Communications and Engagement. Lorna has successfully held senior leadership roles in health charities for more than twenty years and has a diverse background in patient advocacy, mission development, communications, and strategic planning.

Her efforts have been focused on haematological cancers since 2003, at a national (Canada) and global level. Lorna is recognized and respected for strong leadership skills, breadth of knowledge, critical thinking, and patient-focus.

The rich data procured from the biennial Lymphoma Coalition Global Patient Survey on Lymphomas and CLL allows Lorna to truly understand and report on the global patient experience, by subtype, by therapy area, by geographic area, by gender and by age.

As a result of her years of experience in evidence-based advocacy and especially in the haematology field, she is frequently asked to present on patient experience, emerging trends and important issues in the lymphoma and CLL landscape.

Presentation(s):

• Hi Cancer, We Come Bearing Gifts, Antibody-Drug Conjugate

  Thursday, March 23, 2023
  9:30 AM – 10:30 AM EDT